A phase II clinical trial of BH011 injection for the treatment of untreated or chemotherapy-relapsed intermediate- and high-risk non-muscle-invasive bladder cancer
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update:
21 Jun 2022
Note:
-
Adis is an information provider.
-
Final gross price and currency may vary according to local VAT and billing address.
-
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
-
A link to download a PDF version of the trial profile will be included in your email receipt.